节点文献

IL-33/ST2信号通路在肾脏疾病中作用机制的研究进展

Research progress on the mechanism of IL-33/ST2 signaling pathway in kidney diseases

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王倩梁昌昌沈士朋刘茂东白璐

【Author】 WANG Qian;LIANG Changchang;SHEN Shipeng;LIU Maodong;BAI Lu;Department of Nephrology,the Third Hospital of Hebei Medical University;Hebei Key Laboratory for Diabetic Kidney Disease;Kidney Disease Research Center of Hebei Province;

【通讯作者】 白璐;

【机构】 河北医科大学第三医院肾内科河北省糖尿病肾脏疾病重点实验室河北省肾脏病研究中心

【摘要】 白介素-33(interleukin-33,IL-33)是白介素-1的超家族成员,是机体炎症的“预警因子”,当细胞坏死或组织损伤时,IL-33被大量释放,与其受体ST2结合形成复合体从而发挥多种生物学效应。在急性肾损伤、梗阻性肾病、糖尿病肾病、IgA肾病、狼疮性肾炎、移植肾等多种肾脏疾病中IL-33/ST2信号通路被激活,通过调节肾脏固有免疫和适应性免疫反应,在炎症及肾脏纤维化中发挥重要作用。本文综述了IL-33/ST2信号在常见肾脏疾病中的研究进展,希望为肾脏疾病的治疗提供新的靶点和思路。

【Abstract】 Interleukin-33(IL-33) is a member of the interleukin-1 superfamily and a "warning factor" for inflammation in the body. When cells die or tissues are damaged, IL-33 is released in large quantities and binds to its receptor ST2 to form a complex, exerting various biological effects. IL-33/ST2 signaling pathway is activated in many kidney diseases, such as acute renal injury, obstructive nephropathy, diabetes nephropathy, IgA nephropathy,lupus nephritis, and kidney transplantation. It plays an important role in inflammation and renal fibrosis by regulating the intrinsic and adaptive immune responses of the kidney. This article reviews the research progress of IL-33/ST2 signaling in common kidney diseases, hoping to provide new targets and ideas for the treatment of kidney diseases.

【关键词】 白介素-33ST2免疫调节炎症肾脏疾病
【Key words】 interleukin-33ST2immune regulationinflammationkidney diseases
【基金】 河北省中医药管理局科研计划项目(2022408)
  • 【文献出处】 中国临床药理学与治疗学 ,Chinese Journal of Clinical Pharmacology and Therapeutics , 编辑部邮箱 ,2025年08期
  • 【分类号】R692
  • 【下载频次】83
节点文献中: 

本文链接的文献网络图示:

本文的引文网络